Bacteriological outcome of combination versus single-agent treatment for staphylococcal endocarditis.
J Antimicrob Chemother
; 52(5): 820-5, 2003 Nov.
Article
em En
| MEDLINE
| ID: mdl-14519677
ABSTRACT
OBJECTIVE:
To analyse the bacteriological outcome of combination versus single-agent antimicrobial treatment in staphylococcal endocarditis. PATIENTS ANDMETHODS:
Retrospective review of 152 episodes 91 cases of native valve endocarditis (NVE), 74 due to Staphylococcus aureus and 17 due to coagulase-negative staphylococci (CoNS); and 61 cases of prosthetic valve endocarditis (PVE), 29 due to S. aureus and 32 due to CoNS.RESULTS:
Valves from patients with S. aureus NVE treated with any kind of combination antibiotic treatment were no more likely to be culture-negative than those treated with a single agent [19 (45%) of 42 versus 13 (41%) of 32; P = 0.69]. This finding remained unchanged when cases of CoNS NVE were added to the S. aureus group. In PVE, after adjusting for duration of treatment, valves from patients receiving any kind of combination treatment were 5.9 times (95% confidence interval 1.3-27.5) more likely to be culture-negative than those receiving monotherapy (P = 0.024). Patients treated for >14 days were more likely to be culture-negative than those treated for
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Infecções Estafilocócicas
/
Staphylococcus
/
Staphylococcus aureus
/
Implante de Prótese de Valva Cardíaca
/
Endocardite Bacteriana
/
Antibacterianos
Limite:
Humans
Idioma:
En
Revista:
J Antimicrob Chemother
Ano de publicação:
2003
Tipo de documento:
Article
País de afiliação:
Nova Zelândia